• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于死亡证明的 COVID-19 死亡率监测 ICD-10 诊断代码-美国,2020 年 1 月至 12 月。

Death Certificate-Based ICD-10 Diagnosis Codes for COVID-19 Mortality Surveillance - United States, January-December 2020.

出版信息

MMWR Morb Mortal Wkly Rep. 2021 Apr 9;70(14):523-527. doi: 10.15585/mmwr.mm7014e2.

DOI:10.15585/mmwr.mm7014e2
PMID:33830982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8030983/
Abstract

Approximately 375,000 deaths during 2020 were attributed to COVID-19 on death certificates reported to CDC (1). Concerns have been raised that some deaths are being improperly attributed to COVID-19 (2). Analysis of International Classification of Diseases, Tenth Revision (ICD-10) diagnoses on official death certificates might provide an expedient and efficient method to demonstrate whether reported COVID-19 deaths are being overestimated. CDC assessed documentation of diagnoses co-occurring with an ICD-10 code for COVID-19 (U07.1) on U.S. death certificates from 2020 that had been reported to CDC as of February 22, 2021. Among 378,048 death certificates listing U07.1, a total of 357,133 (94.5%) had at least one other ICD-10 code; 20,915 (5.5%) had only U07.1. Overall, 97.3% of 357,133 death certificates with at least one other diagnosis (91.9% of all 378,048 death certificates) were noted to have a co-occurring diagnosis that was a plausible chain-of-event condition (e.g., pneumonia or respiratory failure), a significant contributing condition (e.g., hypertension or diabetes), or both. Overall, 70%-80% of death certificates had both a chain-of-event condition and a significant contributing condition or a chain-of-event condition only; this was noted for adults aged 18-84 years, both males and females, persons of all races and ethnicities, those who died in inpatient and outpatient or emergency department settings, and those whose manner of death was listed as natural. These findings support the accuracy of COVID-19 mortality surveillance in the United States using official death certificates. High-quality documentation of co-occurring diagnoses on the death certificate is essential for a comprehensive and authoritative public record. Continued messaging and training (3) for professionals who complete death certificates remains important as the pandemic progresses. Accurate mortality surveillance is critical for understanding the impact of variants of SARS-CoV-2, the virus that causes COVID-19, and of COVID-19 vaccination and for guiding public health action.

摘要

在向疾病预防控制中心报告的死亡证明中,约有 37.5 万人的死亡归因于 COVID-19(1)。有人担心,有些死亡被不当归因于 COVID-19(2)。分析官方死亡证明上的国际疾病分类,第十版(ICD-10)诊断可能提供一种便捷有效的方法来证明报告的 COVID-19 死亡是否被高估。疾病预防控制中心评估了截至 2021 年 2 月 22 日向疾病预防控制中心报告的 2020 年美国死亡证明上与 COVID-19(U07.1)ICD-10 代码同时出现的诊断的文件记录。在列出 U07.1 的 378048 份死亡证明中,共有 357133 份(94.5%)至少有一个其他 ICD-10 代码;20915 份(5.5%)仅有 U07.1。总的来说,在至少有一个其他诊断的 357133 份死亡证明中(占所有 378048 份死亡证明的 91.9%),有 97.3%被记录为同时存在一个可能的连锁事件条件(例如肺炎或呼吸衰竭)、一个重要的促成条件(例如高血压或糖尿病)或两者兼而有之。总的来说,70%-80%的死亡证明既有连锁事件条件又有重要的促成条件,或者只有连锁事件条件;这在 18-84 岁的成年人、男性和女性、所有种族和族裔的人、在住院、门诊或急诊环境中死亡的人以及死因列为自然的人身上都有体现。这些发现支持了使用官方死亡证明进行 COVID-19 死亡率监测的准确性。在死亡证明上高质量地记录同时出现的诊断对于全面和权威的公共记录至关重要。随着大流行的继续,为填写死亡证明的专业人员提供持续的信息和培训(3)仍然很重要。准确的死亡率监测对于了解导致 COVID-19 的严重急性呼吸系统综合征冠状病毒 2 变异株的影响以及 COVID-19 疫苗的效果以及为公共卫生行动提供指导至关重要。

相似文献

1
Death Certificate-Based ICD-10 Diagnosis Codes for COVID-19 Mortality Surveillance - United States, January-December 2020.基于死亡证明的 COVID-19 死亡率监测 ICD-10 诊断代码-美国,2020 年 1 月至 12 月。
MMWR Morb Mortal Wkly Rep. 2021 Apr 9;70(14):523-527. doi: 10.15585/mmwr.mm7014e2.
2
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.美国疾病控制与预防中心国家健康报告:2005 - 2013年美国发病和死亡的主要原因以及相关行为风险和保护因素
MMWR Suppl. 2014 Oct 31;63(4):3-27.
3
Surveillance for Silicosis Deaths Among Persons Aged 15-44 Years - United States, 1999-2015.1999 - 2015年美国15 - 44岁人群矽肺病死亡监测
MMWR Morb Mortal Wkly Rep. 2017 Jul 21;66(28):747-752. doi: 10.15585/mmwr.mm6628a2.
4
Examination of Cause-of-Death Data Quality Among New York City Deaths Due to Cancer, Pneumonia, or Diabetes From 2010 to 2014.2010 年至 2014 年纽约市因癌症、肺炎或糖尿病导致的死亡原因数据质量检查。
Am J Epidemiol. 2018 Jan 1;187(1):144-152. doi: 10.1093/aje/kwx207.
5
Evaluation of Oklahoma's Electronic Death Registration System and Event Fatality Markers for Disaster-Related Mortality Surveillance - Oklahoma USA, May 2013.评估俄克拉荷马州的电子死亡登记系统和灾难相关死亡率监测的事件标记——美国俄克拉荷马州,2013 年 5 月。
Prehosp Disaster Med. 2019 Apr;34(2):125-131. doi: 10.1017/S1049023X19000189.
6
Excess Mortality Associated With the COVID-19 Pandemic-Los Angeles County, March-September 2020.2020年3月至9月洛杉矶县与新冠疫情相关的超额死亡率
J Public Health Manag Pract. 2021;27(3):233-239. doi: 10.1097/PHH.0000000000001344.
7
Death by mental retardation? The influence of ambiguity on death certificate coding error for adults with intellectual disability.因智力障碍而死亡?歧义对智障成年人死亡证明编码错误的影响。
J Intellect Disabil Res. 2013 Dec;57(12):1183-90. doi: 10.1111/j.1365-2788.2012.01614.x. Epub 2012 Sep 7.
8
Use of Death Certificates to Identify Tuberculosis-Related Deaths in Washington State.利用死亡证明确定华盛顿州与结核病相关的死亡情况。
J Public Health Manag Pract. 2017 Mar/Apr;23(2):e12-e15. doi: 10.1097/PHH.0b013e3182aaa1d8.
9
Using Death Certificates to Explore Changes in Alcohol-Related Mortality in the United States, 1999 to 2017.利用死亡证明探讨 1999 年至 2017 年美国与酒精相关的死亡率变化
Alcohol Clin Exp Res. 2020 Jan;44(1):178-187. doi: 10.1111/acer.14239. Epub 2020 Jan 7.
10
Disentangling the relationship between cancer mortality and COVID-19 in the US.解析美国癌症死亡率与 COVID-19 之间的关系。
Elife. 2024 Aug 27;13:RP93758. doi: 10.7554/eLife.93758.

引用本文的文献

1
Assessment of COVID-19 death surveillance during the pandemic period in Recife.累西腓大流行期间新冠病毒病死亡监测评估
Rev Bras Enferm. 2025 Jun 27;78(2):e20230408. doi: 10.1590/0034-7167-2023-0408. eCollection 2025.
2
Characteristics of influenza, SARS-CoV-2, and RSV surveillance systems that utilise ICD-coded data: a systematic review.利用国际疾病分类编码数据的流感、新冠病毒和呼吸道合胞病毒监测系统的特征:一项系统综述
J Glob Health. 2025 May 23;15:04177. doi: 10.7189/jogh.15.04177.
3
Bayesian poisson regression tensor train decomposition model for learning mortality pattern changes during COVID-19 pandemic.用于学习新冠疫情期间死亡率模式变化的贝叶斯泊松回归张量列车分解模型
J Appl Stat. 2024 Oct 10;52(5):1017-1039. doi: 10.1080/02664763.2024.2411608. eCollection 2025.
4
Beyond the underlying cause of death: an algorithm to study multi-morbidity at death.超越潜在死因:一种研究死亡时多种疾病并存情况的算法
Popul Health Metr. 2024 Dec 18;22(1):36. doi: 10.1186/s12963-024-00356-8.
5
Unrecognised COVID-19 deaths in central Europe: The importance of cause-of-death certification for the COVID-19 burden assessment.中欧未识别的 COVID-19 死亡病例:死因认证对于 COVID-19 负担评估的重要性。
PLoS One. 2024 Jul 16;19(7):e0307194. doi: 10.1371/journal.pone.0307194. eCollection 2024.
6
COVID-19 Death Determination Methods, Minnesota, USA, 2020-2022.2020-2022 年美国明尼苏达州 COVID-19 死亡判定方法。
Emerg Infect Dis. 2024 Jul;30(7):1352-1360. doi: 10.3201/eid3007.231522.
7
Trends and disparities in deaths among young persons in the US during the COVID-19 pandemic.美国在新冠疫情期间年轻人死亡趋势及差异
Ann Epidemiol. 2024 Mar;91:37-43. doi: 10.1016/j.annepidem.2024.01.009. Epub 2024 Feb 2.
8
Immediate cause and the role of multimorbidity in deaths associated with COVID 19 among hospitalized patients in a low resource district in Kerala India: A record-based case-control analysis.印度喀拉拉邦一个资源匮乏地区住院患者中与新冠病毒病相关死亡的直接原因及多种疾病的作用:基于记录的病例对照分析
J Family Med Prim Care. 2023 Aug;12(8):1593-1601. doi: 10.4103/jfmpc.jfmpc_2061_22. Epub 2023 Aug 29.
9
Estimate of COVID-19 Deaths, China, December 2022-February 2023.2022 年 12 月至 2023 年 2 月期间中国 COVID-19 死亡人数的估计。
Emerg Infect Dis. 2023 Oct;29(10):2121-2124. doi: 10.3201/eid2910.230585. Epub 2023 Aug 28.
10
Meta-Analysis of COVID-19 BAL Single-Cell RNA Sequencing Reveals Alveolar Epithelial Transitions and Unique Alveolar Epithelial Cell Fates.COVID-19 BAL 单细胞 RNA 测序的荟萃分析揭示了肺泡上皮细胞的转化和独特的肺泡上皮细胞命运。
Am J Respir Cell Mol Biol. 2023 Dec;69(6):623-637. doi: 10.1165/rcmb.2023-0077OC.

本文引用的文献

1
Provisional Mortality Data - United States, 2020.暂定死亡率数据-美国,2020 年。
MMWR Morb Mortal Wkly Rep. 2021 Apr 9;70(14):519-522. doi: 10.15585/mmwr.mm7014e1.
2
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
3
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System.新型冠状病毒病 2019(COVID-19)相关住院的危险因素:COVID-19 相关住院监测网络和行为危险因素监测系统。
Clin Infect Dis. 2021 Jun 1;72(11):e695-e703. doi: 10.1093/cid/ciaa1419.
4
Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET).通过美国 2019 年冠状病毒病(COVID-19)相关住院监测网络(COVID-NET)确定的住院成年患者入住重症监护病房和院内死亡的危险因素。
Clin Infect Dis. 2021 May 4;72(9):e206-e214. doi: 10.1093/cid/ciaa1012.
5
Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020.估算 2020 年 3 月至 5 月美国 COVID-19 大流行期间的超额死亡人数。
JAMA Intern Med. 2020 Oct 1;180(10):1336-1344. doi: 10.1001/jamainternmed.2020.3391.
6
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
7
Principles and Pitfalls: a Guide to Death Certification.原则与陷阱:死亡证明指南
Clin Med Res. 2015 Jun;13(2):74-82; quiz 83-4. doi: 10.3121/cmr.2015.1276.